Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture

Arch Osteoporos. 2016 Dec;11(1):37. doi: 10.1007/s11657-016-0292-1. Epub 2016 Oct 31.

Abstract

This review provides a critical analysis of currently available approaches to increase bone mass, structure and strength through drug therapy and of possible direct intra-osseous interventions for the management of patients at imminent risk of hip fracture.

Purpose: Osteoporotic hip fractures represent a particularly high burden in morbidity-, mortality- and health care-related costs. There are challenges and unmet needs in the early prevention of hip fractures, opening the perspective of new developments for the management of osteoporotic patients at imminent and/or at very high risk of hip fracture. Amongst them, preventive surgical intervention needs to be considered.

Methods: A European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)/International Osteoporosis Foundation (IOF) working group reviewed the presently available intervention modalities including preventive surgical options for hip fragility. This paper represents a summary of the discussions.

Results: Prevention of hip fracture is currently based on regular physical activity; prevention of falls; correction of nutritional deficiencies, including vitamin D repletion; and pharmacological intervention. However, efficacy of these various measures to reduce hip fractures is at most 50% and may need months or years before becoming effective. To face the challenges of early prevention of hip fractures for osteoporotic patients at imminent and/or at very high risk of hip fracture, preventive surgical intervention needs further investigation.

Conclusion: Preventive surgical intervention needs to be appraised for osteoporotic patients at imminent and/or at very high risk of hip fracture.

Keywords: BMD; Bone strength; Fracture; Osteoporosis; Surgical treatment; Treatment.

Publication types

  • Review

MeSH terms

  • Aged
  • Bone Density / drug effects
  • Bone Density Conservation Agents* / classification
  • Bone Density Conservation Agents* / therapeutic use
  • Disease Management
  • Female
  • Hip Fractures* / etiology
  • Hip Fractures* / prevention & control
  • Humans
  • Male
  • Middle Aged
  • Orthopedic Procedures / methods*
  • Osteoporosis / complications
  • Osteoporosis / drug therapy*
  • Osteoporotic Fractures / prevention & control*
  • Preventive Medicine / methods

Substances

  • Bone Density Conservation Agents